Espoir KAMBALE KAVUNGERE – Advanced Drug Delivery and Biomaterials (ADDB)
Green-synthesis of Zinc Oxide Nanoparticles for the Treatment of Type 2 Diabetes Mellitus
Promotor: Prof Ana Beloqui
Co-promotors : Prof Joëlle QUETIN-LECLERCQ and Prof Patrick Memvanga (Université de Kinshasa)
Related publications:
- Kambale EK, Quetin-Leclercq J, Memvanga PB, Beloqui A. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics 2022, 14, 2135, doi.org/10.3390/pharmaceutics14102135.
- Kambale EK, Katemo FM, Quetin-Leclercq J, Memvanga PB, Beloqui A. “Green”-synthesized zinc oxide nanoparticles and plant extracts: A comparison between synthesis processes and antihyperglycemic activity. Int. J. Pharm. 2023, 635, 122715, doi:10.1016/j.ijpharm.2023.122715.
- Kambale EK, Domingues I, Zhang W, Marotti V, Chen C, Hughes K, Quetin-Leclercq, J.; Memvanga, P.B.; Beloqui, A. “Green”-Synthesized versus Chemically-Synthesized Zinc Oxide Nanoparticles: In Vivo Antihyperglycemic Activity and Pharmacokinetics. Int. J. Pharm. 2024, 650, doi:10.1016/j.ijpharm.2023.123701.
This thesis defence took place on June 21, 2024.
